Browse > Article

Extract of Linum usitatissimum L. inhibits Coxsackievirus B3 Replication through AKT Signal Modulation  

Shin, Ha-Hyeon (Department of Biomedical Science, Jungwon University)
Moon, Sung-Jin (Department of Biomedical Science, Jungwon University)
Lim, Byung-Kwan (Department of Biomedical Science, Jungwon University)
Kim, Jin Hee (College of Herbal Bio-industry, Daegu Haany University)
Publication Information
Korean Journal of Pharmacognosy / v.49, no.4, 2018 , pp. 291-297 More about this Journal
Abstract
Coxsackievirus B3 (CVB3) is a very well-known causative agent for viral myocarditis and meningitis in human. However, the effective vaccine and therapeutic drug are not developed yet. CVB3 infection activates host cell AKT signaling. Inhibition of AKT signaling pathway may attenuate CVB3 replication and prevent CVB3-mediate viral myocarditis. In this study, we determined antiviral effect of the selected natural plant extract to develop a therapeutic drug for CVB3 treatment. We screened several chemically extracted natural compounds by using HeLa cell-based cell survival assay. Among them, Linum usitatissimum L. extract was selected for antiviral drug candidate. L. usitatissimum extract significantly decreased CVB3 replication and cell death in CVB3 infected HeLa cells with no cytotoxicity. CVB3 protease 2A induced eIF4G1 cleavage and viral capsid protein VP1 production were dramatically decreased by L. usitatissimum extract treatment. In addition, virus positive and negative strand genome amplification were significantly decreased by 1 mg/ml L. usitatissimum extract treatment. Especially, L. usitatissimum extract was associated with inhibition of AKT signal and maintain mTOR activity. In contrast, Atg12 and LC3 expression were not changed by L. usitatissimum extract treatment. In this study, the potential AKT signal inhibitor, L. usitatissimum extract, was significantly inhibited viral genome replication and protein production by inhibition of AKT signal. These results suggested that L. usitatissimum extract is a novel therapeutic agent for treatment of CVB3-mediated diseases.
Keywords
Coxsackievirus B3; AKT; eIF4G1; Plant extract;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kim, J. M., Lim, B. K., Ho, S. H., Yun, S. H., Shin, J. O., Park, E. M., Kim, D. K., Kim, S. and Jeon, E. S. (2006) TNFR-Fc fusion protein expressed by in vivo electroporation improves survival rates and myocardial injury in coxsackievirus induced murine myocarditis. Biochem. Biophys. Res. Commun. 344: 765-771.   DOI
2 Yun, S. H., Lee, W. G., Kim, Y. C., Ju, E. S., Lim, B. K., Choi, J. O., Kim, D. K. and Jeon, E. S. (2012) Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis. J. Infect. Dis. 205: 491-497.   DOI
3 Lim, B. K. and Kim, J. H. (2014) ORI2 inhibits coxsackievirus replication and myocardial inflammation in experimental murine myocarditis. Biol. Pharm. Bull. 37: 1650-1654.   DOI
4 Lim, B. K., Choi, J. H., Nam, J. H., Gil, C. O., Shin, J. O., Yun, S. H., Kim, D. K. and Jeon, E. S. (2006) Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis. Cardiovasc. Res. 71: 517-526.   DOI
5 Lim, B. K., Yun, S. H., Ju, E. S., Kim, B. K., Lee, Y. J., Yoo, D. K., Kim, Y. C. and Jeon, E. S. (2015) Soluble coxsackievirus B3 3C protease inhibitor prevents cardiomyopathy in an experimental chronic myocarditis murine model. Virus. Res. 199: 1-8.   DOI
6 Lee, S. M., Lee, Y. J., Yoon, J. J., Kang, D. G. and Lee, H. S. (2014) Effect of Poria cocos on puromycin aminonucleoside-induced nephrotic syndrome in rats. Evid. Based. Complement. Alternat. Med. 2014: 570420.
7 Badorff, C., Berkely, N., Mehrotra, S., Talhouk, J. W., Rhoads, R. E. and Knowlton, K. U. (2000) Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue. J. Biol. Chem. 275: 11191-11197.   DOI
8 Huber, S. A. and Lodge, P. A. (1986) Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. Am. J. Pathol. 122: 284-291.
9 Lee, Y. G., Park, J. H., Jeon, E. S., Kim, J. H. and Lim, B. K. (2016) Fructus amomi cardamomi extract inhibit coxsackievirus-B3 induced myocarditis in murine myocarditis model. J. Microbiol. Biotechnol. 26: 2012-2018.   DOI
10 Lim, B. K., Xiong, D., Dorner, A., Youn, T. J., Yung, A., Liu, T. I., Gu, Y., Dalton, N. D., Wright, A. T., Evans, S. M., Chen, J., Peterson, K. L., McCulloch, A. D., Yajima, T. and Knowlton, K. U. (2008) Coxsackievirus and adenovirus receptor (CAR) mediates atrioventricular-node function and connexin 45 localization in the murine heart. J. Clin. Invest. 118: 2758-2770.   DOI
11 Herskowitz, A., Beisel, K. W., Wolfgram, L. J. and Rose, N. R. (1985) Coxsackievirus B3 murine myocarditis: wide pathologic spectrum in genetically defined inbred strains. Hum. Pathol. 16: 671-673.   DOI
12 Baboonian, C., Davies, M. J., Booth, J. C. and McKenna, W. J. (1997) Coxsackie B viruses and human heart disease. Curr. Top. Microbiol. Immunol. 223: 31-52.
13 Liu, P., Martino, T., Opavsky, M. A. and Penninger, J. (1996) Viral myocarditis: balance between viral infection and immune response. Can. J. Cardiol. 12: 935-943.
14 Martino, T. A., Liu, P. and Sole, M. J. (1994) Viral infection and the pathogenesis of dilated cardiomyopathy. Circ. Res. 74: 182-188.   DOI
15 DeLuca, J. A. A., Garcia-Villatoro, E. L. and Allred, C. D. (2018) Flaxseed bioactive compounds and colorectal cancer prevention. Curr. Oncol. Rep. 20: 59.   DOI
16 Chen, T. C., Weng, K. F., Chang, S. C., Lin, J. Y., Huang, P. N. and Shih, S. R. (2008) Development of antiviral agents for enteroviruses. J. Antimicrob. Chemother. 62: 1169-1173.   DOI
17 Schuman, B. E., Squires, E. J. and Leeson, S. (2000) Effect of dietary flaxseed, flax oil and n-3 fatty acid supplement on hepatic and plasma characteristics relevant to fatty liver haemorrhagic syndrome in laying hens. Br. Poult. Sci. 41: 465-472.   DOI
18 Yi, H., Hwang, K. T., Regenstein, J. M. and Shin, S. W. (2014) Fatty Acid Composition and Sensory Characteristics of Eggs Obtained from Hens Fed Flaxseed Oil, Dried Whitebait and/or Fructo-oligosaccharide. Asian-Australas. J. Anim. Sci. 27: 1026-1034.   DOI
19 Troina, A. A., Figueiredo, M. S., Passos, M. C., Reis, A. M., Oliveira, E., Lisboa, P. C. and Moura, E. G. (2012) Flaxseed bioactive compounds change milk, hormonal and biochemical parameters of dams and offspring during lactation. Food. Chem. Toxicol. 50: 2388-2396.   DOI
20 Caligiuri, S. P., Edel, A. L., Aliani, M. and Pierce, G. N. (2014) Flaxseed for hypertension: implications for blood pressure regulation. Curr. Hypertens. Rep. 16: 499.   DOI
21 Feldman, A. M. and McNamara, D. (2000) Myocarditis. N. Engl. J. Med. 343: 1388-1398.   DOI
22 Han, J. Y., Jeong, H. I., Park, C. W., Yoon, J., Ko, J., Nam, S. J. and Lim, B. K. (2018) Cholic acid attenuates ER stress-induced cell death in coxsackievirus-B3 infection. J. Microbiol. Biotechnol. 28: 109-114.   DOI
23 Esfandiarei, M., Luo, H., Yanagawa, B., Suarez, A., Dabiri, D., Zhang, J. and McManus, B. M. (2004) Protein kinase B/Akt regulates coxsackievirus B3 replication through a mechanism which is not caspase dependent. J. Virol. 78: 4289-4298.   DOI
24 Tan, E. L., Wong, A. P. and Poh, C. L. (2010) Development of potential antiviral strategy against coxsackievirus B4. Virus. Res. 150: 85-92.   DOI